Everest Medicines Ltd

HKSE:01952 (China)   Ordinary Shares
HK$ 19.62 (-3.35%) Jul 19
At Loss
P/B:
1.15
Market Cap:
HK$ 6.27B ($ 802.20M)
Enterprise V:
HK$ 4.29B ($ 549.04M)
Volume:
1.06M
Avg Vol (2M):
2.06M
Trade In:
Volume:
1.06M
At Loss
Avg Vol (2M):
2.06M

Business Description

Description
Everest Medicines Ltd is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of potentially novel or differentiated therapies and vaccines to address critical unmet medical needs initially in the Asia Pacific markets and eventually around the world. Its product pipeline includes; Nefecon (TarpeyoTM), EVER001 (previously known as XNW1011), PTX-COVID19-B, Eravacycline (Xerava), EVER206 (also known as SPR206), and others.
Name Current Vs Industry Vs History
Cash-To-Debt 4.6
Equity-to-Asset 0.86
Debt-to-Equity 0.1
Debt-to-EBITDA -0.69
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.1
Distress
Grey
Safe
Beneish M-Score 4.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.75
9-Day RSI 46.34
14-Day RSI 45.26
6-1 Month Momentum % 21.91
12-1 Month Momentum % -3.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.36
Quick Ratio 8.29
Cash Ratio 7.83
Days Inventory 147.82
Days Sales Outstanding 54.11
Days Payable 411.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.9
Shareholder Yield % 1.75

Financials

HKSE:01952's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Everest Medicines Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 137.742
EPS (TTM) (HK$) -2.953
Beta 2.97
Volatility % 83.68
14-Day RSI 45.26
14-Day ATR (HK$) 0.91745
20-Day SMA (HK$) 19.7225
12-1 Month Momentum % -3.94
52-Week Range (HK$) 14.34 - 32.2
Shares Outstanding (Mil) 319.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Everest Medicines Ltd Filings

Filing Date Document Date Form
No Filing Data

Everest Medicines Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Everest Medicines Ltd Frequently Asked Questions

What is Everest Medicines Ltd(HKSE:01952)'s stock price today?
The current price of HKSE:01952 is HK$19.62. The 52 week high of HKSE:01952 is HK$32.20 and 52 week low is HK$14.34.
When is next earnings date of Everest Medicines Ltd(HKSE:01952)?
The next earnings date of Everest Medicines Ltd(HKSE:01952) is .
Does Everest Medicines Ltd(HKSE:01952) pay dividends? If so, how much?
Everest Medicines Ltd(HKSE:01952) does not pay dividend.

Press Release

Subject Date
No Press Release